Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

NCT02213224 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Nonalcoholic Fatty Liver Disease (NAFLD)

Interventions

DRUG: Perindopril
DRUG: Telmisartan
DRUG: Amlodipine

Sponsor

Nanfang Hospital, Southern Medical University